18-47841734-T-C
Position:
Variant summary
Our verdict is Benign. Variant got -14 ACMG points: 0P and 14B. BP4_StrongBP6_ModerateBS1BS2
The NM_005901.6(SMAD2):c.*93A>G variant causes a 3 prime UTR change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.00102 in 1,466,538 control chromosomes in the GnomAD database, including 16 homozygotes. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Likely benign (★).
Frequency
Genomes: 𝑓 0.0050 ( 6 hom., cov: 32)
Exomes 𝑓: 0.00057 ( 10 hom. )
Consequence
SMAD2
NM_005901.6 3_prime_UTR
NM_005901.6 3_prime_UTR
Scores
2
Clinical Significance
Conservation
PhyloP100: 2.21
Genes affected
SMAD2 (HGNC:6768): (SMAD family member 2) The protein encoded by this gene belongs to the SMAD, a family of proteins similar to the gene products of the Drosophila gene 'mothers against decapentaplegic' (Mad) and the C. elegans gene Sma. SMAD proteins are signal transducers and transcriptional modulators that mediate multiple signaling pathways. This protein mediates the signal of the transforming growth factor (TGF)-beta, and thus regulates multiple cellular processes, such as cell proliferation, apoptosis, and differentiation. This protein is recruited to the TGF-beta receptors through its interaction with the SMAD anchor for receptor activation (SARA) protein. In response to TGF-beta signal, this protein is phosphorylated by the TGF-beta receptors. The phosphorylation induces the dissociation of this protein with SARA and the association with the family member SMAD4. The association with SMAD4 is important for the translocation of this protein into the nucleus, where it binds to target promoters and forms a transcription repressor complex with other cofactors. This protein can also be phosphorylated by activin type 1 receptor kinase, and mediates the signal from the activin. Alternatively spliced transcript variants have been observed for this gene. [provided by RefSeq, May 2012]
Genome browser will be placed here
ACMG classification
Classification made for transcript
Verdict is Benign. Variant got -14 ACMG points.
BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.48).
BP6
Variant 18-47841734-T-C is Benign according to our data. Variant chr18-47841734-T-C is described in ClinVar as [Likely_benign]. Clinvar id is 1177743.Status of the report is criteria_provided_single_submitter, 1 stars.
BS1
Variant frequency is greater than expected in population afr. gnomad4 allele frequency = 0.00496 (756/152368) while in subpopulation AFR AF= 0.0169 (702/41578). AF 95% confidence interval is 0.0158. There are 6 homozygotes in gnomad4. There are 349 alleles in male gnomad4 subpopulation. Median coverage is 32. This position pass quality control queck.
BS2
High AC in GnomAd4 at 756 AD gene.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | UniProt |
---|---|---|---|---|---|---|---|
SMAD2 | NM_005901.6 | c.*93A>G | 3_prime_UTR_variant | 11/11 | ENST00000262160.11 | ||
SMAD2 | NM_001003652.4 | c.*93A>G | 3_prime_UTR_variant | 11/11 | |||
SMAD2 | NM_001135937.3 | c.*93A>G | 3_prime_UTR_variant | 10/10 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|
SMAD2 | ENST00000262160.11 | c.*93A>G | 3_prime_UTR_variant | 11/11 | 1 | NM_005901.6 | |||
SMAD2 | ENST00000356825.8 | c.*93A>G | 3_prime_UTR_variant | 10/10 | 1 | P1 | |||
SMAD2 | ENST00000402690.6 | c.*93A>G | 3_prime_UTR_variant | 11/11 | 1 | ||||
SMAD2 | ENST00000586040.5 | c.*93A>G | 3_prime_UTR_variant | 9/9 | 5 | P1 |
Frequencies
GnomAD3 genomes AF: 0.00491 AC: 748AN: 152250Hom.: 6 Cov.: 32
GnomAD3 genomes
AF:
AC:
748
AN:
152250
Hom.:
Cov.:
32
Gnomad AFR
AF:
Gnomad AMI
AF:
Gnomad AMR
AF:
Gnomad ASJ
AF:
Gnomad EAS
AF:
Gnomad SAS
AF:
Gnomad FIN
AF:
Gnomad MID
AF:
Gnomad NFE
AF:
Gnomad OTH
AF:
GnomAD4 exome AF: 0.000566 AC: 744AN: 1314170Hom.: 10 Cov.: 19 AF XY: 0.000485 AC XY: 320AN XY: 659618
GnomAD4 exome
AF:
AC:
744
AN:
1314170
Hom.:
Cov.:
19
AF XY:
AC XY:
320
AN XY:
659618
Gnomad4 AFR exome
AF:
Gnomad4 AMR exome
AF:
Gnomad4 ASJ exome
AF:
Gnomad4 EAS exome
AF:
Gnomad4 SAS exome
AF:
Gnomad4 FIN exome
AF:
Gnomad4 NFE exome
AF:
Gnomad4 OTH exome
AF:
GnomAD4 genome AF: 0.00496 AC: 756AN: 152368Hom.: 6 Cov.: 32 AF XY: 0.00468 AC XY: 349AN XY: 74518
GnomAD4 genome
AF:
AC:
756
AN:
152368
Hom.:
Cov.:
32
AF XY:
AC XY:
349
AN XY:
74518
Gnomad4 AFR
AF:
Gnomad4 AMR
AF:
Gnomad4 ASJ
AF:
Gnomad4 EAS
AF:
Gnomad4 SAS
AF:
Gnomad4 FIN
AF:
Gnomad4 NFE
AF:
Gnomad4 OTH
AF:
Alfa
AF:
Hom.:
Bravo
AF:
Asia WGS
AF:
AC:
7
AN:
3478
ClinVar
Significance: Likely benign
Submissions summary: Benign:1
Revision: criteria provided, single submitter
LINK: link
Submissions by phenotype
not provided Benign:1
Likely benign, criteria provided, single submitter | clinical testing | GeneDx | Dec 05, 2018 | - - |
Computational scores
Source:
Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
CADD
Benign
DANN
Benign
RBP_binding_hub_radar
RBP_regulation_power_radar
Splicing
Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
Details are displayed if max score is > 0.2
Find out detailed SpliceAI scores and Pangolin per-transcript scores at